TR199701536T1 - Use of benzimidazoles in the manufacture of a drug for the treatment of leukemia. - Google Patents

Use of benzimidazoles in the manufacture of a drug for the treatment of leukemia.

Info

Publication number
TR199701536T1
TR199701536T1 TR97/01536T TR9701536T TR199701536T1 TR 199701536 T1 TR199701536 T1 TR 199701536T1 TR 97/01536 T TR97/01536 T TR 97/01536T TR 9701536 T TR9701536 T TR 9701536T TR 199701536 T1 TR199701536 T1 TR 199701536T1
Authority
TR
Turkey
Prior art keywords
leukemia
treatment
benzimidazoles
drug
manufacture
Prior art date
Application number
TR97/01536T
Other languages
Turkish (tr)
Inventor
Berger Camden James
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Publication of TR199701536T1 publication Critical patent/TR199701536T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Bu bulus, özellikle insan ve sicak kanli hayvalarda löseminin tedavisi için yararli olan bir farmasötik terkiptir.Bu terkip, bir benzimidazol türevini ihtiva eder.This invention is a pharmaceutical composition that is particularly useful for the treatment of leukemia in human and warm blooded animals. This composition contains a derivative of benzimidazole.

TR97/01536T 1995-06-07 1996-05-22 Use of benzimidazoles in the manufacture of a drug for the treatment of leukemia. TR199701536T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47381795A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
TR199701536T1 true TR199701536T1 (en) 1998-02-21

Family

ID=23881113

Family Applications (1)

Application Number Title Priority Date Filing Date
TR97/01536T TR199701536T1 (en) 1995-06-07 1996-05-22 Use of benzimidazoles in the manufacture of a drug for the treatment of leukemia.

Country Status (17)

Country Link
EP (1) EP0831816A1 (en)
JP (1) JPH11506732A (en)
KR (1) KR19990022617A (en)
CN (1) CN1186433A (en)
AR (1) AR003137A1 (en)
AU (1) AU717382B2 (en)
BR (1) BR9608730A (en)
CA (1) CA2223435A1 (en)
CZ (1) CZ391197A3 (en)
HU (1) HUP9802634A3 (en)
IL (1) IL118424A0 (en)
NO (1) NO975660L (en)
PL (1) PL324026A1 (en)
SK (1) SK168697A3 (en)
TR (1) TR199701536T1 (en)
WO (1) WO1996040122A1 (en)
ZA (1) ZA964373B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
EP2251010A1 (en) 2009-05-08 2010-11-17 Sygnis Bioscience GmbH & Co. KG Use of thiabendazole and derivatives thereof for the therapy of neurological conditions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL134354C (en) * 1963-05-23
FR2155888A1 (en) * 1971-10-13 1973-05-25 Agot Aime Solid anthelmintic composn - for more economical treatment of ruminants

Also Published As

Publication number Publication date
BR9608730A (en) 1999-06-29
NO975660D0 (en) 1997-12-05
CN1186433A (en) 1998-07-01
HUP9802634A3 (en) 1999-05-28
CA2223435A1 (en) 1996-12-19
EP0831816A1 (en) 1998-04-01
KR19990022617A (en) 1999-03-25
HUP9802634A2 (en) 1999-03-29
JPH11506732A (en) 1999-06-15
PL324026A1 (en) 1998-05-11
WO1996040122A1 (en) 1996-12-19
AU717382B2 (en) 2000-03-23
CZ391197A3 (en) 1998-05-13
IL118424A0 (en) 1996-09-12
AU5802096A (en) 1996-12-30
ZA964373B (en) 1996-09-02
AR003137A1 (en) 1998-07-08
SK168697A3 (en) 1998-12-02
NO975660L (en) 1998-02-09

Similar Documents

Publication Publication Date Title
TR199701536T1 (en) Use of benzimidazoles in the manufacture of a drug for the treatment of leukemia.
TR199701535T1 (en) Use of bis-1,2,4-triazoles in the manufacture of a drug for the treatment of cancers.
TR200002860T2 (en) New crystal forms of an antiviral benzimidazole composition.
TR199500832A2 (en) Benzimidazole derivatives and their use in medical therapy and pharmaceutical formulations containing them.
TR199903053T2 (en) Benzimidazole trevleri.
TR199801315T2 (en) Use of a ppar-alpha and ppar-gamma antagonist for the treatment of syndrome X.
BRPI0407305A (en) Cannabinoid receptor ligands and their uses
ATE229511T1 (en) BENZIMIDAZOLES, THEIR PRODUCTION AND THEIR USE AS MEDICINAL PRODUCTS
TR200100047T2 (en) Thiobenzimidazole derivatives
ES2121193T3 (en) DERIVATIVES OF BENCIMIDAZOLES.
BR0307508A (en) Compound, pharmaceutical composition, and methods of treating or preventing pain and inflammation and treating disease
TR200000223T2 (en) Heterocyclic derivatives blocking the XA factor
TR199701534T1 (en) Use of 1,2,4-triazole derivatives in the manufacture of a drug for the treatment of cancers.
BR0107628A (en) 1,2-diarylbenzimidazoles for treating diseases that are associated with microglial activation
TR200101633T2 (en) Pharmaceutical composition
DE60115466D1 (en) ACTIVE PROCESSORS OF IMIDAZOPYRIDINE DERIVATIVES
TR200100637T2 (en) New natural product derivatives
EE200300129A (en) Use of distamycin alpha-haloacryloyl derivative
ATE199641T1 (en) TERPENDERIVATES (SARCODICTYINES) AS ANTI-CANCER AGENT
TR200002847T2 (en) Form VI 5, 6-dichloro-2- (isopropylamino) -1- (beta-L-ribofuranosyl) -1H-benzimidazole.
EE9900278A (en) Angiotensin II antagonists for use in the treatment of symptomatic heart failure
NO20020914D0 (en) Alkoxy-substituted benzimidazole compounds, preparations containing them and their applications
TR199802496T2 (en) Formulation for the treatment of congestive heart failure.
SE9702191D0 (en) Coposition and methods for the treatment of inflammatory dideases
TR200200111T2 (en) Therapeutic and prophylactic agents for neoplasms